Soo koob maqaalka:  Daraasad cusub ayaa muujisay in dumarka ay weli halis ugu jiraan kansarka naasaha sanado kadib markay joojiyeen daaweynta bedelka hoormoonka. Daawada hormoonka bedelka ah waxay kordhisaa khatarta dumarka ee kansarka naasaha ilaa sideed sano kadib markay joojiso daweynta, saynisyahannadu waxay ka digeen. Natiijooyinka cusub waxay ka yimaadeen khubaro sameeyay mid ka mid ah daraasadaha ugu waaweyn adduunka ee ku saabsan saameynta HRT - oo loo isticmaalo in lagu yareeyo saameynta menopause. Waxbarashada Caafimaadka Haweenka ee Maraykanka iyo Daraasada Million Women ee UK ayaa labaduba soo bandhigay caddeymo adag oo muujinaya in HRT ay kordhiso halista dumarka ee kansarka naasaha, uurka iyo ugxan-biyoodka. Daraasada Million Women Study, oo ay iska kaashadeen Cancer Research UK iyo NHS, natiijooyinkeedu waxay soo jeediyeen in haweenka isticmaalaya isku darka HRT ay leeyihiin laba jeer halista kansarka naasaha marka la barbar dhigo kuwa aan isticmaalin. waxayna ogaadeen in dumarka isticmaalayo HRT in ka badan 10 sano, khatartoodu ay kororto. Hada, saynisyahannada ku xeel dheer daraasada caafimaadka dumarka waxay ka digeen, kaddib markii ay sameeyeen baaritaano dheeraad ah, in dumarka qaata daaweynta isku darka ah ee loo yaqaano estrogen-ka iyo progesterone-ka HRT ay sii wadaan in ay leeyihiin khatar sarreysa oo ah kansarka naasaha, ilaa sideed sano kadib markay joojiyaan daweynta. Ka dib markaad soo marto xilliga caadada, ugxan-jiifka dumarka ayaa joojiya soo saarista hoormoonka estrogenka. Waxay keentaa calaamadaha caadada oo ay ka mid yihiin kuleylka iyo isbedelka niyadda. HRT waxay jidhka ku daweysaa hormoonnada galmada ee dumarka. Waxaa jira sadex nooc oo kala ah, daaweynta galmada ee loo yaqaano (HRT) oo ay ku jirto estrogen-ka oo kaliya, daaweynta galmada ee loo yaqaano (HRT) oo loo yaqaano (cyclic) oo ah in estrogen si joogto ah loo qaato laakiin progesterone la siiyo bil kasta ama saddexdii biloodba mar, iyo daaweynta galmada ee loo yaqaano (continuous combined HRT) oo ah in labada hoormoon ee dumarka la qaato isla waqtigaas. Horraantii 1990-yadii, daraasado yaryar ayaa soo jeediyay in daaweynta ay yareyn karto halista haweenka ee cudurka wadnaha ee wadnaha iyo osteoporosis. Si loo baaro in tani ay tahay kiiska, Hindisaha Caafimaadka Haweenka ee Mareykanka ayaa loo xilsaaray baaritaan. Waxay qorteen in ka badan 26,000 oo dumar ah oo da'doodu u dhaxayso 50 ilaa 79 sano. Dhanka kale, daraasad kale oo muhiim ah oo lagu sameeyay UK, Million Women Study, ayaa lagu baaray saameynta HRT ay ku leedahay dumarka...
HRT waxay kordhisaa khatarta cudurka ilaa sideed sano kadib joojinta daaweynta. Waxay khuseysaa dadka qaata HRT isku dhafan - estrogen iyo progesterone. Cilmibaadhis ay sameeyeen saynisyahano ka tirsan mid ka mid ah daraasadihii ugu weynaa ee abid lagu sameeyo HRT. Laakiin dumarka qaata daaweynta oestrogen-ka oo kaliya waxay leeyihiin khatar yar.